Shareholding disclosure

Basilea Pharmaceutica AG, Allschwil

Collectively declared rate

3%

Threshold

Fell below threshold

Timeline

Published

19.08.2008

Transaction

07.08.2008

Transfer date

07.08.2008

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T6538D6293

Beneficial owner

AXA S.A

Declared address

AXA SA, Paris

AXA Investment Managers Deutschland GmbH, Hauptniederlassung, Innere Kanalstrasse 95, 50823 Köln, Deutschland, meldet gemäss Mitteilung vom 11. August 2008 an die Basilea Pharmaceutica AG, dass AXA S.A., 25, avenue Matignon, 75008 Paris, Frankreich, und AllianceBernstein L.P., New York, NY 10105, USA, die beide zum gleichen Konzern gehören, ihre Beteiligungen an der Basilea Pharmaceutica AG am 7. August 2008 auf 280 920 Namenaktien, entsprechend einem Stimmrechtsanteil von 2,94% reduziert haben.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open